IL315033A - Tgf-b antibodies - Google Patents

Tgf-b antibodies

Info

Publication number
IL315033A
IL315033A IL315033A IL31503324A IL315033A IL 315033 A IL315033 A IL 315033A IL 315033 A IL315033 A IL 315033A IL 31503324 A IL31503324 A IL 31503324A IL 315033 A IL315033 A IL 315033A
Authority
IL
Israel
Prior art keywords
tgf
antibodies
Prior art date
Application number
IL315033A
Other languages
English (en)
Hebrew (he)
Inventor
Lore Mari?N
Boeck Gitte De
Sophie Lucas
Fanny Lambert
Der Woning Sebastian Paul Van
St?phanie LIENART
Original Assignee
Univ Catholique Louvain
Lore Mari?N
Boeck Gitte De
Sophie Lucas
Fanny Lambert
Der Woning Sebastian Paul Van
St?phanie LIENART
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Catholique Louvain, Lore Mari?N, Boeck Gitte De, Sophie Lucas, Fanny Lambert, Der Woning Sebastian Paul Van, St?phanie LIENART filed Critical Univ Catholique Louvain
Publication of IL315033A publication Critical patent/IL315033A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL315033A 2022-03-09 2023-03-09 Tgf-b antibodies IL315033A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2203269.2A GB202203269D0 (en) 2022-03-09 2022-03-09 TGF-Beta antibodies
PCT/EP2023/056082 WO2023170241A1 (en) 2022-03-09 2023-03-09 TGF-β ANTIBODIES

Publications (1)

Publication Number Publication Date
IL315033A true IL315033A (en) 2024-10-01

Family

ID=81175458

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315033A IL315033A (en) 2022-03-09 2023-03-09 Tgf-b antibodies

Country Status (9)

Country Link
US (1) US20250188161A1 (https=)
EP (1) EP4490186A1 (https=)
JP (1) JP2025508073A (https=)
CN (1) CN119173533A (https=)
AU (1) AU2023229972A1 (https=)
CA (1) CA3245104A1 (https=)
GB (1) GB202203269D0 (https=)
IL (1) IL315033A (https=)
WO (2) WO2023170241A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
GB2461546B (en) 2008-07-02 2010-07-07 Argen X Bv Antigen binding polypeptides
RS61778B1 (sr) * 2013-05-06 2021-06-30 Scholar Rock Inc Kompozicije i postupci za modulaciju faktora rasta
ES2860952T3 (es) 2013-08-01 2021-10-05 Univ Catholique Louvain Proteína anti-garp y usos de la misma
EP3139957A4 (en) * 2014-05-06 2018-04-25 Scholar Rock, Inc. Compositions and methods for growth factor modulation
WO2016125017A1 (en) 2015-02-03 2016-08-11 Universite Catholique De Louvain Anti-garp protein and uses thereof
AU2018387829B2 (en) 2017-12-22 2024-12-19 Argenx Bvba Bispecific antigen binding construct

Also Published As

Publication number Publication date
EP4490186A1 (en) 2025-01-15
WO2023170242A1 (en) 2023-09-14
JP2025508073A (ja) 2025-03-21
WO2023170241A1 (en) 2023-09-14
GB202203269D0 (en) 2022-04-20
CN119173533A (zh) 2024-12-20
AU2023229972A1 (en) 2024-09-12
CA3245104A1 (en) 2023-09-14
US20250188161A1 (en) 2025-06-12

Similar Documents

Publication Publication Date Title
CR20230573A (es) ANTICUERPOS ANTI-SIRP-alfa
IL311039A (en) Anti-cd3 antibodies
EP3950061A4 (en) ANTIBODY PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE
DK4214240T3 (da) Anti-ccr8-antistoffer
EP4463485A4 (en) Tetrahedral antibodies
EP4081547A4 (en) Novel anti-fgfr2b antibodies
IL311043A (en) Anti-il-11rα antibodies
IL310245A (en) Anti-hla-g antibodies
EP4532558A4 (en) ANTI-ROR1 ANTIBODIES
EP4181950A4 (en) Engineered anti-her2 bispecific proteins
EP4277927A4 (en) NEW ANTI-GREMLIN-1 ANTIBODIES
IL304800A (en) Bispecific antibody
EP4081539A4 (en) Novel anti-fgfr2b antibodies
EP4414388A4 (en) NEW ANTI-L1CAM ANTIBODY
EP4144370A4 (en) BISPECIFIC ANTIBODY
EP4392455A4 (en) ANTI-CD-25 ANTIBODIES
DK4157876T3 (da) Anti-pd-1-antistoffer
EP4481051A4 (en) D-ALLULOSE-3-MODIFIED EPIMERASE
EP4163301C0 (en) Humanized Anti-GPC-1 Antibody
IL299767A (en) Anti-αlpha-4-βeta-7 antibodies
EP4230079C0 (de) Schliesse
DK4172199T3 (da) Alfa-synuklein-protofibril-bindende antistoffer
EP4097139A4 (en) PLAP-CD3 EPSILON BISPECIFIC ANTIBODIES
EP4471057A4 (en) ANTI-CXCL1 HUMAN ANTIBODY
EP4431606A4 (en) ANTI-EPHA4 ANTIBODIES